Skip to main content

Basic human research study of novel glaucoma endpoints and identification of optimal patient populations for neuroprotection trials

Clinical Trial Grant
Duke Scholars

Administered By

Ophthalmology, Glaucoma

Awarded By

Novartis Pharmaceuticals Corporation

Start Date

June 10, 2020

End Date

August 22, 2025
 

Administered By

Ophthalmology, Glaucoma

Awarded By

Novartis Pharmaceuticals Corporation

Start Date

June 10, 2020

End Date

August 22, 2025